CAC (gated) Algorithm vs EchoGo® Heart Failure
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A and Tool B are adjacent healthcare-AI tools, both FDA-cleared and operating within the Cardiology AI and Radiology & Imaging AI categories. Tool A specializes in quantifying coronary artery calcium from cardiac CT scans to assess coronary artery health, while Tool B analyzes echocardiograms to detect HFpEF and support heart failure diagnoses. Their primary difference lies in the imaging modality they process and the specific cardiac condition they target.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
BunkerHill Health's CAC (gated) Algorithm automatically detects and quantifies coronary artery calcium from non-contrast ECG-gated cardiac CT scans, aiding physicians in assessing coronary artery health and supporting opportunistic detection of cardiovascular disease. Ultromics' EchoGou00ae Heart Failure analyzes routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF), providing insights to support clinical decisions and enhance the diagnosis and management of heart failure.
The CAC (gated) Algorithm specifically analyzes non-contrast ECG-gated cardiac CT scans. EchoGou00ae Heart Failure analyzes routine echocardiograms, specifically a single apical 4-chamber view from echo video clips.
The CAC (gated) Algorithm integrates into physicians' standard workflows, providing calcium segmentation and quantification, and pre-populates structured reports for radiologist review and approval. EchoGou00ae Heart Failure offers seamless integration with existing workflows and IT stacks, delivering automated structured reports via DICOM workflow to PACS within 20-30 minutes.
The CAC (gated) Algorithm provides automatic detection and quantification of coronary artery calcium, including calcium segmentation and overall/vessel-specific scores, to assist in evaluating coronary artery health. EchoGou00ae Heart Failure delivers AI-powered HFpEF detection, a continuous probability score reflecting the likelihood of HFpEF, and insights within 20-30 minutes in automated structured reports.
Pricing for the CAC (gated) Algorithm requires direct contact with BunkerHill Health, but as of April 1, 2026, CMS introduced a national billing code under the Hospital Outpatient Prospective Payment System (OPPS) for algorithmic analysis of coronary artery calcium. EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316.08 per analysis, and is covered by Medicare and select commercial insurers. It is also eligible for New Technology Add-on Payment (NTAP) in the hospital inpatient setting.
The CAC (gated) Algorithm demonstrated a Cohen's weighted kappa of 0.972 (95%CI 0.958, 0.987) for 4-category score group assessment, exceeding the primary acceptance criteria of 0.90. EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF, and was trained on over 10 years of outcome data.